Treatment News : Bee Venom: The Next Anti-HIV Agent? A Proof-of-Concept Study Says Yes

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 13, 2013

Bee Venom: The Next Anti-HIV Agent? A Proof-of-Concept Study Says Yes

Nanoparticles filled with a toxin called melittin that’s found in bee venom can destroy HIV and have a benign effect on surrounding cells, Medical News Today reports. Publishing the results of their proof-of-concept study in the March 2013 issue of Antiviral Therapy, researchers from Washington University School of Medicine in St. Louis added “protective bumpers” to the surface of the melittin-filled nanoparticles. These bumpers prevented normal cells, which are most often larger, from coming into contact with the melittin-coated surface. HIV, on the other hand, would fit in between these bumpers and the melittin would fuse with its viral envelope, rupture the envelope and tear it from the virus—effectively killing the virus.

This line of attack is different from the one taken by antiretrovirals (ARVs), which arrest different phases in the virus’s lifecycle instead of killing it entirely. Such a novel approach would be able to keep HIV from beginning an infection of a cell in the first place. Researchers hope melittin may be used as a vaginal microbicide or as a salvage therapy for people with HIV who have failed numerous classes of ARVs. In addition, because melittin attacks cells indiscriminately, it may prove an effective therapy for hepatitis B and C viruses (HBV/HCV) and other pathogens that count on a viral envelope for survival.

To read the study abstract, click here.

To read the Medical News Today report, click here. 

Search: nanoparticles, toxin, bee venom, melittin, Medical News Today, Antiviral Therapy, Washington University School of Medicine, protective bumpers, HIV, hepatitis C, hepatitis B.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (4 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.